US Stock MarketDetailed Quotes

REPL Replimune

Watchlist

6.450
-0.520-7.46%

Close Apr 19 16:00 ET

6.530
+0.080+1.24%

Post 19:57 ET

395.95MMarket Cap-2041P/E (TTM)

Replimune Stock Forum

Jaguar8

Apr 8 06:49

$Replimune(REPL.US)$
NEWS
Replimune Group, Inc. announced positive interim results from the ARTACUS Phase 1/2 clinical trial evaluating RP1 monotherapy for skin cancers in transplant patients, showing a 34.8% overall response rate with good durability. The treatment was well-tolerated and resulted in immune activation.

Moomoo AI

Nov 8, 2023 21:50

Despite no recent insider transactions, those over the past year fail to inspire confidence. The modest insider ownership provides reasonable company alignment. Investors are warned of several signs in Replimune Group.

Insiders Could Have Profited By Holding Onto Replimune Group Shares Despite 26% Drop

LeicesterM

Oct 27, 2021 15:02

$Oncorus Inc(ONCR.US)$
The reason why I am interested in oncolytic virus is that the virus itself is a kind of drug, and at the same time, the virus can become the carrier of other drugs. This dual property is not possessed by other drugs at present, and it is up to us to fully exploit this function.$Replimune(REPL.US)$$Candel Therapeutics(CADL.US)$

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall